# NeuImmune, Inc. — Form D

NeuImmune, Inc. of SYKESVILLE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2021-07-15. The offering totals $20K, of which $20K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-07-15
- Form: D
- Accession: 0001860169-21-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20K
- Amount sold: $20K
- Minimum investment: $20K
- Investors: 1
- Date of first sale: 2021-07-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-406464

## Issuer

- Name: NeuImmune, Inc.
- CIK: 0001860169
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1500 FANNIE DORSEY RD, SYKESVILLE, MD, 21784
- Phone: 2403146507

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Kenneth C Carter | Director | SYKESVILLE, MD |
| Thomas R Fuerst | Director | SYKESVILLE, MD |
| Thomas R Fuerst | Executive Officer | SYKESVILLE, MD |
| Mark D Hankins | Executive Officer | SYKESVILLE, MD |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-05-12](https://search.stillhousedata.com/formd/0001860169-21-000002) | D | $105K | $105K |

## More

- [CIK 1860169 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1860169&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001860169-21-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.